ZOLINZA Side Effects

6994583-5 | Pancytopenia, Pneumonia, Septic Shock
on Sep 14, 2010 Male patient from UNITED STATES , weighting 167.6 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Zolinza (View Usage). Patient experienced the following unwanted or unexpected effects: pancytopenia, pneumonia (What is pneumonia?), septic shock. Zolinza dosage: 7 Days On, 7 Days Off. During the same period patient was treated with REVLIMID (21 Days On, 7 Days Off) (View Revlimid Review and Revlimid Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized and became disabled.

6844984-0 | Delusion, Hallucination, Psychotic Disorder
Patient was taking Zolinza (View Usage). Patient had the following side effects: delusion, hallucination, psychotic disorder (What is psychotic disorder?) on Jun 25, 2010 from UNITED STATES Additional patient health information: Male patient , child 8 years of age, weighting 53.00 lb, was diagnosed with central nervous system neoplasm and. Zolinza dosage: 230 Mg/m[2]/daily/po. During the same period patient was treated with VELCADE (1.3 Mg/m[2]/daily/iv) (View Velcade Review and Velcade Label ), PERIACTIN (Po) (View Periactin Review and Periactin Label ), DECADRON (Po) (View Decadron Review and Decadron Label ).

6817865-6 | Gastrointestinal Haemorrhage
Adverse event was reported on Jun 23, 2010 by a Male patient taking Zolinza (View Usage) (Dosage: ) was diagnosed with mycosis fungoides, deep vein thrombosis (What is deep vein thrombosis?) and. Location: UNITED STATES , 74 years of age, weighting 174.2 lb, After Zolinza was administered, patient had the following side effects: gastrointestinal haemorrhage. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), COUMADIN (View Coumadin Review and Coumadin Label ), ZOCOR (View Zocor Review and Zocor Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), INSULIN (View Insulin Review and Insulin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), NORCO (1 Or 2 Tablets Q/6h) (View Norco Review and Norco Label ), MORPHINE (0.5-2mg) (View Morphine Review and Morphine Label ). Patient was hospitalized.

6703412-6 | Abdominal Pain, Anaemia, Constipation, Decreased Appetite, Deep Vein Thrombosis, Hypermagnesaemia, Hypocalcaemia, Hypoglycaemia
on Apr 20, 2010 Male patient from FRANCE , 51 years of age, was diagnosed with lung neoplasm malignant and was treated with Zolinza (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), anaemia, constipation (What is constipation?), decreased appetite, deep vein thrombosis (What is deep vein thrombosis?), hypermagnesaemia, hypocalcaemia, hypoglycaemia. Zolinza dosage: 400 Mg/daily;po, 400 Mg/daily;po, 400 Mg/daily;po. During the same period patient was treated with GEMCITABINE (2380 Mg/1x;iv, 1850 Mg/1x;iv, 1850 Mg/1x;iv, 1850 Mg/1x;iv) (View Gemcitabine Review and Gemcitabine Label ), CISPLATIN (143 Mg/1x;iv, 139 Mg/1x;iv) (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.


6684877-5 | Abdominal Distension, Anaemia, Asthenia, Balance Disorder, Bicytopenia, Constipation, Decreased Appetite, Diarrhoea, Dizziness
on Apr 05, 2010 Male patient from UNITED STATES , 72 years of age, was diagnosed with mycosis fungoides and was treated with Zolinza (View Usage). Patient had the following side effects: abdominal distension, anaemia, asthenia, balance disorder, bicytopenia, constipation (What is constipation?), decreased appetite, diarrhoea, dizziness (What is dizziness?). Zolinza dosage: . During the same period patient was treated with TARGRETIN (View Targretin Review and Targretin Label ), LYRICA (View Lyrica Review and Lyrica Label ), ZOCOR (View Zocor Review and Zocor Label ). Patient was hospitalized.

6661466-X | Asthenia, Diarrhoea, Gastric Ulcer, Lung Infection, Pneumonia, Skin Laceration, Small Intestinal Obstruction, Staphylococcal Sepsis, Syncope
Patient was taking Zolinza (View Usage). After Zolinza was administered, patient had the following side effects: asthenia, diarrhoea, gastric ulcer, lung infection, pneumonia (What is pneumonia?), skin laceration, small intestinal obstruction, staphylococcal sepsis, syncope on Mar 24, 2010 from UNITED STATES Additional patient health information: Male patient , 72 years of age, was diagnosed with mycosis fungoides and. Zolinza dosage: . Patient was hospitalized.

6649016-5 | Disease Progression, Dizziness, Dyspnoea, Failure To Thrive, Fatigue, Hyponatraemia, Hypoxia, Syncope
Adverse event was reported on Mar 22, 2010 by a Female patient taking Zolinza (View Usage) (Dosage: ) was diagnosed with lung neoplasm malignant and. Location: UNITED STATES , 60 years of age, weighting 145.5 lb, Patient experienced the following unwanted or unexpected effects: disease progression, dizziness (What is dizziness?), dyspnoea, failure to thrive, fatigue, hyponatraemia, hypoxia, syncope. During the same period patient was treated with BORTEZOMIB (View Bortezomib Review and Bortezomib Label ). Patient was hospitalized.

6637393-0 | Nail Discolouration, T-cell Lymphoma
on Mar 11, 2010 Male patient from UNITED STATES , 70 years of age, weighting 205.0 lb, was diagnosed with mycosis fungoides and was treated with Zolinza (View Usage). Patient had the following side effects: nail discolouration, t-cell lymphoma. Zolinza dosage: . During the same period patient was treated with IMODIUM (View Imodium Review and Imodium Label ), LIPITOR (View Lipitor Review and Lipitor Label ), GENTEAL (View Genteal Review and Genteal Label ).

6634823-5 | Disease Progression, Dizziness, Dyspnoea, Failure To Thrive, Fatigue, Hyponatraemia, Hypoxia, Syncope
on Mar 10, 2010 Female patient from UNITED STATES , 60 years of age, weighting 145.5 lb, was diagnosed with lung neoplasm malignant and was treated with Zolinza (View Usage). After Zolinza was administered, patient had the following side effects: disease progression, dizziness (What is dizziness?), dyspnoea, failure to thrive, fatigue, hyponatraemia, hypoxia, syncope. Zolinza dosage: . During the same period patient was treated with BORTEZOMIB (View Bortezomib Review and Bortezomib Label ). Patient was hospitalized.

6627036-4 | Acute Myeloid Leukaemia, Condition Aggravated, Febrile Neutropenia, Myelodysplastic Syndrome, Squamous Cell Carcinoma
Patient was taking Zolinza (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia, condition aggravated, febrile neutropenia, myelodysplastic syndrome, squamous cell carcinoma on Feb 24, 2010 from FRANCE Additional patient health information: Male patient , 68 years of age, was diagnosed with myelodysplastic syndrome and. Zolinza dosage: 400 Mg/daily, Po, 400 Mg/daily, Po. During the same period patient was treated with CYTARABINE (38 Mg/daily, Sc, 38 Mg/daily, Sc) (View Cytarabine Review and Cytarabine Label ). Patient was hospitalized.

6610969-2 |
Adverse event was reported on Jan 22, 2010 by a Female patient taking Zolinza (View Usage) (Dosage: Po) was diagnosed with mycosis fungoides and. Location: FRANCE , 75 years of age, .

6602579-8 | Nail Discolouration, T-cell Lymphoma
on Feb 19, 2010 Male patient from UNITED STATES , 70 years of age, weighting 205.0 lb, was diagnosed with mycosis fungoides and was treated with Zolinza (View Usage). After Zolinza was administered, patient had the following side effects: nail discolouration, t-cell lymphoma. Zolinza dosage: . During the same period patient was treated with IMODIUM (View Imodium Review and Imodium Label ), LIPITOR (View Lipitor Review and Lipitor Label ), GENTEAL (View Genteal Review and Genteal Label ).

6565890-5 |
on Jan 19, 2010 Female patient from FRANCE , 75 years of age, was diagnosed with mycosis fungoides and was treated with Zolinza (View Usage). . Zolinza dosage: Po.

6529212-8 | Abdominal Pain, Anaemia, Asthenia, Constipation, Decreased Appetite, Deep Vein Thrombosis, Hypermagnesaemia, Hypocalcaemia
Patient was taking Zolinza (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), anaemia, asthenia, constipation (What is constipation?), decreased appetite, deep vein thrombosis (What is deep vein thrombosis?), hypermagnesaemia, hypocalcaemia on Sep 24, 2009 from FRANCE Additional patient health information: Male patient , 51 years of age, was diagnosed with lung neoplasm malignant and. Zolinza dosage: 400 Mg/daily Po ; 400 Mg/daily Po. During the same period patient was treated with GEMCITABINE (2380 Mg/1x Iv ; 1850 Mg/1x Iv ; 1850 Mg/1x Iv ;) (View Gemcitabine Review and Gemcitabine Label ), CISPLATIN (143 Mg/1x Iv ; 139 Mg/1x Iv) (View Cisplatin Review and Cisplatin Label ), ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ). Patient was hospitalized.

6527351-9 | Acute Pulmonary Oedema, Blood Glucose Increased, Blood Ph Decreased, Blood Pressure Decreased, Bundle Branch Block Left, Cardiac Arrest, Cardiac Failure Congestive, Diarrhoea
Adverse event was reported on Dec 31, 2009 by a Male patient taking Zolinza (View Usage) (Dosage: ) was diagnosed with mycosis fungoides, t-cell lymphoma stage iv and. Location: UNITED STATES , 77 years of age, weighting 154.3 lb, After Zolinza was administered, patient had the following side effects: acute pulmonary oedema, blood glucose increased, blood ph decreased, blood pressure decreased, bundle branch block left, cardiac arrest (What is cardiac arrest?), cardiac failure congestive, diarrhoea. Patient was hospitalized.

6524332-6 | Acute Pulmonary Oedema, Cardiac Failure Congestive, Diarrhoea, Mycosis Fungoides, Myocardial Infarction, Pneumonia, Respiratory Failure
on Dec 10, 2009 Male patient from UNITED STATES , 77 years of age, weighting 154.3 lb, was diagnosed with mycosis fungoides and was treated with Zolinza (View Usage). Patient experienced the following unwanted or unexpected effects: acute pulmonary oedema, cardiac failure congestive, diarrhoea, mycosis fungoides, myocardial infarction, pneumonia (What is pneumonia?), respiratory failure. Zolinza dosage: . During the same period patient was treated with AUGMENTIN (View Augmentin Review and Augmentin Label ), DARVOCET N 100 (View Darvocet-n 100 Review and Darvocet-n 100 Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ). Patient was hospitalized.

6507782-3 | Acute Pulmonary Oedema, Cardiac Failure Congestive, Diarrhoea, Mycosis Fungoides, Myocardial Infarction, Pneumonia, Respiratory Failure
on Dec 10, 2009 Male patient from UNITED STATES , 77 years of age, weighting 154.3 lb, was diagnosed with mycosis fungoides and was treated with Zolinza (View Usage). Patient had the following side effects: acute pulmonary oedema, cardiac failure congestive, diarrhoea, mycosis fungoides, myocardial infarction, pneumonia (What is pneumonia?), respiratory failure. Zolinza dosage: . During the same period patient was treated with AUGMENTIN (View Augmentin Review and Augmentin Label ), DARVOCET N 100 (View Darvocet-n 100 Review and Darvocet-n 100 Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ). Patient was hospitalized.

6461828-X | Abdominal Pain, Anaemia Postoperative, Diarrhoea, Hypocalcaemia, Hypomagnesaemia, Intestinal Ischaemia, Mesenteric Vein Thrombosis, Metabolic Acidosis, Muscle Spasms
Patient was taking Zolinza (View Usage). After Zolinza was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), anaemia postoperative, diarrhoea, hypocalcaemia, hypomagnesaemia, intestinal ischaemia, mesenteric vein thrombosis, metabolic acidosis, muscle spasms on Nov 23, 2009 from UNITED STATES Additional patient health information: Female patient , 51 years of age, was diagnosed with eosinophilia, anxiety (What is anxiety?), poor quality sleep, osteoporosis (What is osteoporosis?), oedema and. Zolinza dosage: . During the same period patient was treated with MEDROL (View Medrol Review and Medrol Label ), XANAX (View Xanax Review and Xanax Label ), INTERFERON ALFA (View Interferon Alfa Review and Interferon Alfa Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ). Patient was hospitalized.

6457385-4 | Abdominal Pain, Anaemia Postoperative, Diarrhoea, Hypocalcaemia, Hypomagnesaemia, Intestinal Ischaemia, Mesenteric Vein Thrombosis, Metabolic Acidosis, Muscle Spasms
Adverse event was reported on Nov 20, 2009 by a Female patient taking Zolinza (View Usage) (Dosage: ) was diagnosed with eosinophilia, anxiety (What is anxiety?), poor quality sleep, osteoporosis (What is osteoporosis?), oedema and. Location: UNITED STATES , 51 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), anaemia postoperative, diarrhoea, hypocalcaemia, hypomagnesaemia, intestinal ischaemia, mesenteric vein thrombosis, metabolic acidosis, muscle spasms. During the same period patient was treated with MEDROL (View Medrol Review and Medrol Label ), XANAX (View Xanax Review and Xanax Label ), INTERFERON ALFA (View Interferon Alfa Review and Interferon Alfa Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ). Patient was hospitalized.

6443879-4 | Abdominal Pain, Anaemia Postoperative, Diarrhoea, Hypocalcaemia, Hypomagnesaemia, Intestinal Ischaemia, Mesenteric Vein Thrombosis, Metabolic Acidosis, Muscle Spasms
on Nov 11, 2009 Female patient from UNITED STATES , 51 years of age, was diagnosed with eosinophilia, anxiety (What is anxiety?), poor quality sleep, osteoporosis (What is osteoporosis?), oedema and was treated with Zolinza (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), anaemia postoperative, diarrhoea, hypocalcaemia, hypomagnesaemia, intestinal ischaemia, mesenteric vein thrombosis, metabolic acidosis, muscle spasms. Zolinza dosage: . During the same period patient was treated with MEDROL (View Medrol Review and Medrol Label ), XANAX (View Xanax Review and Xanax Label ), INTERFERON ALFA (View Interferon Alfa Review and Interferon Alfa Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ). Patient was hospitalized.

6437994-9 |
on Nov 09, 2009 Male patient from UNITED STATES , 77 years of age, was diagnosed with mycosis fungoides and was treated with Zolinza (View Usage). . Zolinza dosage: . During the same period patient was treated with AUGMENTIN (View Augmentin Review and Augmentin Label ), DARVOCET N 100 (View Darvocet-n 100 Review and Darvocet-n 100 Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ).

6436206-X | Abdominal Pain, Diarrhoea, Intestinal Infarction, Mesenteric Occlusion, Muscle Spasms, Underdose
Patient was taking Zolinza (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), diarrhoea, intestinal infarction, mesenteric occlusion, muscle spasms, underdose on Nov 06, 2009 from UNITED STATES Additional patient health information: Female patient , 51 years of age, was diagnosed with eosinophilia and. Zolinza dosage: . Patient was hospitalized.

6421986-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatinine Increased, Blood Lactate Dehydrogenase Increased, Platelet Count Decreased, Tumour Lysis Syndrome
Adverse event was reported on Oct 21, 2009 by a Female patient taking Zolinza (View Usage) (Dosage: ) was diagnosed with mycosis fungoides and. Location: UNITED STATES , 55 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, blood lactate dehydrogenase increased, platelet count decreased, tumour lysis syndrome. During the same period patient was treated with COMPAZINE (View Compazine Review and Compazine Label ), IMODIUM (View Imodium Review and Imodium Label ).

6414123-9 | Abdominal Pain, Diarrhoea, Intestinal Infarction, Mesenteric Occlusion, Muscle Spasms, Underdose
on Oct 21, 2009 Female patient from UNITED STATES , 51 years of age, was diagnosed with eosinophilia and was treated with Zolinza (View Usage). After Zolinza was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), diarrhoea, intestinal infarction, mesenteric occlusion, muscle spasms, underdose. Zolinza dosage: . Patient was hospitalized.

6414099-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatinine Increased, Blood Lactate Dehydrogenase Increased, Platelet Count Decreased, Tumour Lysis Syndrome
on Oct 21, 2009 Female patient from UNITED STATES , 55 years of age, was diagnosed with mycosis fungoides and was treated with Zolinza (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, blood lactate dehydrogenase increased, platelet count decreased, tumour lysis syndrome. Zolinza dosage: . During the same period patient was treated with COMPAZINE (View Compazine Review and Compazine Label ), IMODIUM (View Imodium Review and Imodium Label ).

6408888-X | Abdominal Pain, Intestinal Infarction, Mesenteric Occlusion, Underdose
Patient was taking Zolinza (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), intestinal infarction, mesenteric occlusion, underdose on Oct 15, 2009 from UNITED STATES Additional patient health information: Female patient , 50 years of age, was diagnosed with eosinophilia and. Zolinza dosage: . Patient was hospitalized.

6406980-7 | Blood Creatinine Increased, Blood Urea Increased, Disease Progression, Malnutrition, White Blood Cell Count Increased
Adverse event was reported on Oct 08, 2009 by a Male patient taking Zolinza (View Usage) (Dosage: 400 Mg Daily Po) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: KOREA, REPUBLIC OF , 73 years of age, After Zolinza was administered, patient had the following side effects: blood creatinine increased, blood urea increased, disease progression, malnutrition, white blood cell count increased. During the same period patient was treated with BORTEZOMIB (2.11 Mg Daily, 2.17 Mg Daily,1.631 Mg Daily, 1.106 Mg Daily) (View Bortezomib Review and Bortezomib Label ). Patient was hospitalized.

6399099-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatinine Increased, Blood Lactate Dehydrogenase Increased, Platelet Count Decreased, Tumour Lysis Syndrome
on Oct 05, 2009 Female patient from UNITED STATES , 55 years of age, was diagnosed with mycosis fungoides and was treated with Zolinza (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, blood lactate dehydrogenase increased, platelet count decreased, tumour lysis syndrome. Zolinza dosage: . During the same period patient was treated with COMPAZINE (View Compazine Review and Compazine Label ), IMODIUM (View Imodium Review and Imodium Label ).

6388909-3 | Abdominal Pain, Anaemia, Asthenia, Constipation, Decreased Appetite, Deep Vein Thrombosis, Hypermagnesaemia
on Sep 24, 2009 Male patient from FRANCE , 51 years of age, was diagnosed with lung neoplasm malignant and was treated with Zolinza (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), anaemia, asthenia, constipation (What is constipation?), decreased appetite, deep vein thrombosis (What is deep vein thrombosis?), hypermagnesaemia. Zolinza dosage: 400 Mg/daily, Po. During the same period patient was treated with GEMCITABINE (2380 Mg/1x, Iv) (View Gemcitabine Review and Gemcitabine Label ), CISPLATIN (143 Mg/1x, Iv) (View Cisplatin Review and Cisplatin Label ), EMEND (View Emend Review and Emend Label ), ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ). Patient was hospitalized.

6346625-8 | Bilirubin Conjugated Increased, Blood Bilirubin Increased, Blood Bilirubin Unconjugated Increased, Bronchopulmonary Aspergillosis, C-reactive Protein Increased, Febrile Neutropenia, Haematocrit Decreased, Haemoglobin Decreased, Platelet Count Decreased
Patient was taking Zolinza (View Usage). After Zolinza was administered, patient had the following side effects: bilirubin conjugated increased, blood bilirubin increased, blood bilirubin unconjugated increased, bronchopulmonary aspergillosis, c-reactive protein increased, febrile neutropenia, haematocrit decreased, haemoglobin decreased, platelet count decreased on Aug 19, 2009 from FRANCE Additional patient health information: Male patient , 76 years of age, was diagnosed with myelodysplastic syndrome and. Zolinza dosage: 400 Mg/daily, Po. During the same period patient was treated with CYTARABINE (Sc) (View Cytarabine Review and Cytarabine Label ). Patient was hospitalized.

6312419-2 | Blood Culture Positive, Cerebrovascular Accident, Deep Vein Thrombosis, Disease Progression, Ischaemic Stroke, Staphylococcal Infection, Visual Field Defect
Adverse event was reported on Aug 05, 2009 by a Female patient taking Zolinza (View Usage) (Dosage: 400 Mg/daily Po) was diagnosed with non-small cell lung cancer and. Location: FRANCE , 44 years of age, Patient experienced the following unwanted or unexpected effects: blood culture positive, cerebrovascular accident, deep vein thrombosis (What is deep vein thrombosis?), disease progression, ischaemic stroke, staphylococcal infection (What is staphylococcal infection?), visual field defect. During the same period patient was treated with GEMCITABINE (1250 Mg/m[2]/daily Iv) (View Gemcitabine Review and Gemcitabine Label ), CISPLATIN (75 Mg/m [2] / Daily Iv) (View Cisplatin Review and Cisplatin Label ), EMEND (View Emend Review and Emend Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), ACETAMINOPHEN PROPOXYPHENE HCL TAB (View Acetaminophen- Propoxyphene Hcl Tab Review and Acetaminophen- Propoxyphene Hcl Tab Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ). Patient was hospitalized and became disabled.

6310740-5 | Alopecia, Nausea, Oedema Peripheral
on Jun 30, 2009 Female patient from UNITED STATES , 59 years of age, was diagnosed with mycosis fungoides and was treated with Zolinza (View Usage). Patient had the following side effects: alopecia, nausea (What is nausea?), oedema peripheral. Zolinza dosage: 400 Mg/daily/po. During the same period patient was treated with FLEXERIL (View Flexeril Review and Flexeril Label ), NEXIUM (View Nexium Review and Nexium Label ), TAGAMET (View Tagamet Review and Tagamet Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ).

6305540-6 | Dialysis, Diarrhoea, Disease Progression, Nausea, Neutropenia, Pleurisy, Renal Failure, Respiratory Failure
on Aug 04, 2009 Male patient from FRANCE , 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Zolinza (View Usage). After Zolinza was administered, patient had the following side effects: dialysis (What is dialysis?), diarrhoea, disease progression, nausea (What is nausea?), neutropenia, pleurisy, renal failure, respiratory failure. Zolinza dosage: 400 Mg/daily Po. During the same period patient was treated with CISPLATIN (75 Mg/m2 /daily Iv) (View Cisplatin Review and Cisplatin Label ), GEMCITABINE (1250 Mg/m2 /daily Iv) (View Gemcitabine Review and Gemcitabine Label ), NOROXIN (Po) (View Noroxin Review and Noroxin Label ), EMEND (View Emend Review and Emend Label ). Patient was hospitalized and became disabled.

6304775-6 | Cachexia, Cardiac Failure, Cellulitis, Dysphagia, Infection, Mood Altered, Pneumonia, Sepsis
Patient was taking Zolinza (View Usage). Patient experienced the following unwanted or unexpected effects: cachexia, cardiac failure, cellulitis (What is cellulitis?), dysphagia, infection (What is infection?), mood altered, pneumonia (What is pneumonia?), sepsis (What is sepsis?) on Jul 27, 2009 from AUSTRALIA Additional patient health information: Male patient , 85 years of age, was diagnosed with mycosis fungoides and. Zolinza dosage: 400 Mg/daily Po, 300 Mg/daily Po. Patient was hospitalized.

6300323-5 | Cachexia, Cardiac Failure, Cellulitis, Dysphagia, Infection, Nausea, Pneumonia
Adverse event was reported on Jul 27, 2009 by a Male patient taking Zolinza (View Usage) (Dosage: 400 Mg/daily Po ; 400 Mg/daily Po ; 300 Mg/daily Po ; 300 Mg/daily Po ;300 Mg/daily Po) was diagnosed with mycosis fungoides and. Location: AUSTRALIA , 85 years of age, Patient had the following side effects: cachexia, cardiac failure, cellulitis (What is cellulitis?), dysphagia, infection (What is infection?), nausea (What is nausea?), pneumonia (What is pneumonia?). Patient was hospitalized.

6295504-3 | Cachexia, Cardiac Failure, Cellulitis, Infection, Pneumonia
on May 28, 2009 Male patient from AUSTRALIA , 85 years of age, was diagnosed with mycosis fungoides and was treated with Zolinza (View Usage). After Zolinza was administered, patient had the following side effects: cachexia, cardiac failure, cellulitis (What is cellulitis?), infection (What is infection?), pneumonia (What is pneumonia?). Zolinza dosage: 400 Mg, Daily, Po, 300 Mg Daily, Po. Patient was hospitalized.

6292987-X | Rash, Thrombocytopenia
on Jul 17, 2009 Female patient from FRANCE , 49 years of age, was diagnosed with non-small cell lung cancer and was treated with Zolinza (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?), thrombocytopenia. Zolinza dosage: 400 Mg/daily, Po. During the same period patient was treated with GEMCITABINE (1250 Mg/m[2]/daily Iv, 1250 Mg/m [2[/daily Iv) (View Gemcitabine Review and Gemcitabine Label ), CISPLATIN (75 Mg/m/m [2]/daily Iv, 75 Mg/m [2]/daily Iv) (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6277884-8 | Hypersensitivity, Mycosis Fungoides
Patient was taking Zolinza (View Usage). Patient had the following side effects: hypersensitivity, mycosis fungoides on Jul 09, 2009 from UNITED STATES Additional patient health information: Female patient , 54 years of age, was diagnosed with mycosis fungoides and. Zolinza dosage: . Patient was hospitalized and became disabled.

6274739-X | Cerebrovascular Accident
Adverse event was reported on Jul 09, 2009 by a Female patient taking Zolinza (View Usage) (Dosage: 400 Mg Daily Po) was diagnosed with non-small cell lung cancer and. Location: FRANCE , 44 years of age, After Zolinza was administered, patient had the following side effects: cerebrovascular accident. During the same period patient was treated with GEMCITABINE (1250 M G/m2 Daily Iv) (View Gemcitabine Review and Gemcitabine Label ), CISPLATIN (75 Mg/m2 Daily Iv) (View Cisplatin Review and Cisplatin Label ), EMEND (View Emend Review and Emend Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), ACETAMINOPHEN PROPOXYPHENE HCL TAB (View Acetaminophen- Propoxyphene Hcl Tab Review and Acetaminophen- Propoxyphene Hcl Tab Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ). Patient was hospitalized.

6269092-1 | Erythema, Mycosis Fungoides, Pruritus, Rash, Skin Plaque
on Jul 09, 2009 Female patient from UNITED STATES , 54 years of age, was diagnosed with mycosis fungoides and was treated with Zolinza (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, mycosis fungoides, pruritus, rash (What is rash?), skin plaque. Zolinza dosage: . Patient was hospitalized and became disabled.

6264447-3 | Bone Marrow Failure, Dehydration, Diarrhoea, Nausea, Thrombocytopenia
on Jun 30, 2009 Female patient from UNITED STATES , 61 years of age, was diagnosed with mycosis fungoides, skin plaque and was treated with Zolinza (View Usage). Patient had the following side effects: bone marrow failure, dehydration, diarrhoea, nausea (What is nausea?), thrombocytopenia. Zolinza dosage: . During the same period patient was treated with INTERFERON GAMMA (View Interferon Gamma Review and Interferon Gamma Label ).

6261060-9 | Hyponatraemia
Patient was taking Zolinza (View Usage). After Zolinza was administered, patient had the following side effects: hyponatraemia on Jun 25, 2009 from UNITED STATES Additional patient health information: Male patient , 52 years of age, weighting 301.0 lb, was diagnosed with rectal cancer and. Zolinza dosage: 300 Mg/daily/po. During the same period patient was treated with VELCADE (1.3 Mg/m[2]/iv) (View Velcade Review and Velcade Label ).

6244001-X | Affective Disorder, Atelectasis, Cachexia, Cardiac Failure, Cellulitis, Disease Recurrence, Lymphoma, Malnutrition, Performance Status Decreased
Adverse event was reported on May 28, 2009 by a Male patient taking Zolinza (View Usage) (Dosage: 400 Mg/daily Po ; 400 Mg/daily Po) was diagnosed with mycosis fungoides and. Location: AUSTRALIA , 85 years of age, Patient experienced the following unwanted or unexpected effects: affective disorder, atelectasis, cachexia, cardiac failure, cellulitis (What is cellulitis?), disease recurrence, lymphoma (What is lymphoma?), malnutrition, performance status decreased. Patient was hospitalized.

6239656-X | Renal Failure
on Jun 17, 2009 Male patient from UNITED STATES , 89 years of age, was diagnosed with mycosis fungoides and was treated with Zolinza (View Usage). Patient had the following side effects: renal failure. Zolinza dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ARICEPT (View Aricept Review and Aricept Label ), NAMENDA (View Namenda Review and Namenda Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ZANTAC (View Zantac Review and Zantac Label ), PAROXETINE (View Paroxetine Review and Paroxetine Label ), HALDOL (View Haldol Review and Haldol Label ), COMPAZINE (View Compazine Review and Compazine Label ).

6233296-4 | Renal Failure
on Jun 15, 2009 Male patient from UNITED STATES , 89 years of age, was diagnosed with mycosis fungoides and was treated with Zolinza (View Usage). After Zolinza was administered, patient had the following side effects: renal failure. Zolinza dosage: .

6198035-4 | Skin Hyperpigmentation
Patient was taking Zolinza (View Usage). Patient experienced the following unwanted or unexpected effects: skin hyperpigmentation on Jan 22, 2009 from UNITED STATES Additional patient health information: Female patient , 61 years of age, was diagnosed with mycosis fungoides and. Zolinza dosage: .

6198033-0 | Anorexia, Asthenia, Dehydration, Fatigue, Haemorrhage, Hyperglycaemia, Open Wound
Adverse event was reported on Jan 21, 2009 by a Female patient taking Zolinza (View Usage) (Dosage: 400 Mg/daily/po) was diagnosed with mycosis fungoides and. Location: UNITED STATES , 86 years of age, weighting 128.0 lb, Patient had the following side effects: anorexia, asthenia, dehydration, fatigue, haemorrhage, hyperglycaemia, open wound.

6198030-5 | Alopecia, Chills, Dysgeusia, Eye Swelling, Ocular Hyperaemia, Rash, Skin Exfoliation
on Feb 13, 2009 Female patient from UNITED STATES , 76 years of age, was diagnosed with mycosis fungoides and was treated with Zolinza (View Usage). After Zolinza was administered, patient had the following side effects: alopecia, chills, dysgeusia, eye swelling, ocular hyperaemia, rash (What is rash?), skin exfoliation. Zolinza dosage: 400 Mg/daily/po.

6198004-4 | Therapeutic Response Decreased
on Mar 02, 2009 Male patient from UNITED STATES , 39 years of age, was diagnosed with mycosis fungoides and was treated with Zolinza (View Usage). Patient experienced the following unwanted or unexpected effects: therapeutic response decreased. Zolinza dosage: 400 Mg/daily/po.

6185119-X | Balance Disorder, Fatigue, Herpes Zoster, Lymphopenia, Opportunistic Infection, Paraesthesia
Patient was taking Zolinza (View Usage). Patient had the following side effects: balance disorder, fatigue, herpes zoster, lymphopenia, opportunistic infection, paraesthesia on Apr 30, 2009 from UNITED STATES Additional patient health information: Female patient , 70 years of age, was diagnosed with mantle cell lymphoma and. Zolinza dosage: 400 Mg/unk/po. During the same period patient was treated with VELCADE (1.3 Mg/m[2]/daily/iv) (View Velcade Review and Velcade Label ).